YAP1 and in situ carcinoma: In the early stages of bladder cancer, including CIS and NMIBC, genomic alterations induce molecular changes such as dysregulation of the YAP1/JUN-NUAK2-YAP1 positive feedback loop and abnormal activation of the RhoGEF-RhoGTPase-YAP/TAZ cascade.